Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Enovix (ENVX) Asset Writedowns and Impairment (2023 - 2024)

Enovix (ENVX) has disclosed Asset Writedowns and Impairment for 2 consecutive years, with $9000.0 as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, Asset Writedowns and Impairment changed N/A year-over-year to $9000.0, compared with a TTM value of $3.2 million through Dec 2025, changed 0.0%, and an annual FY2024 reading of $38.3 million, up 767.33% over the prior year.
  • Asset Writedowns and Impairment was $9000.0 for Q4 2024 at Enovix, down from $3.1 million in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $4.4 million in Q3 2023 and bottomed at $9000.0 in Q4 2024.